Skip to main content

Loading market data...

INSP

Inspire Medical Systems, Inc.

NYSE • United states

$71.51

+$0.17

(+0.24%)

Source: Yahoo Finance · Quote time Oct 21, 2026 14:48 GMT+0000

Management
Credibility
Score

Inspire Medical Systems, Inc. (INSP)

Unavailable

Quotes may be delayed

$2.07B

Market Cap

50,858

Volume

15.3

P/E Ratio

Unavailable

Div Yield

Inspire Medical Systems, Inc. Price Chart

Loading price history…

Management Credibility Analysis

Unavailable

Verified Management Score Unavailable

Management credibility requires sourced guidance and earnings history.

Upcoming Catalysts

Verified event feed

Verified Catalysts Unavailable

No sourced upcoming event feed is configured for this stock yet.

Company profile

No description available

Chief executive: Not disclosed
Headquarters: 5500 WAYZATA BLVD, GOLDEN VALLEY, MN
Founded: Not disclosed

📈 Company Timeline

Major business events

Positive

Negative

Neutral

13 Aug 2026

Large-holder ownership filing

A holder reported or amended a beneficial ownership position of more than 5% in Inspire Medical Systems, Inc..

12 Aug 2026

Large-holder ownership filing

A holder reported or amended a beneficial ownership position of more than 5% in Inspire Medical Systems, Inc..

4 Aug 2026

Inspire Medical Systems, Inc. filed Form 10-Q

Inspire Medical Systems, Inc. submitted Form 10-Q to the SEC for the period ending Jun 30, 2026.

4 Aug 2026

Inspire Medical Systems, Inc. reported Operating or financial results

Inspire Medical Systems, Inc. filed an 8-K covering operating or financial results, Regulation FD disclosure, supporting financial statements or exhibits.

31 Jul 2026

Large-holder ownership filing

A holder reported or amended a beneficial ownership position of more than 5% in Inspire Medical Systems, Inc..

Capital Structure & Financial Position

Financial strength and liquidity analysis

Cash and equivalents (USD)$127.76M

Total assets (USD)$925.99M

Total liabilities (USD)$100.41M

Shareholders' equity (USD)$825.58M

Long-term debt (USD)$21.40M

Source: SEC EDGAR company facts (opens in a new tab) Balance sheet dated 30 Jun 2026

Peer Comparison - Health Care

Company	Price	Market Cap
LLY - Eli Lilly and Company	$1,276.13 Yahoo Finance	$1.20T
JNJ - Johnson & Johnson	$256.74 Yahoo Finance	$618.71B
ABBV - AbbVie Inc.	$284.80 Yahoo Finance	$503.28B
UNH - UnitedHealth Group Incorporated	$418.43 Yahoo Finance	$375.58B
MRK - Merck & Co., Inc.	$148.55 Yahoo Finance	$366.50B

📋 Corporate Actions

Recent and upcoming corporate events

Verified Corporate Actions Unavailable

Dividend, buyback, split, and spin-off feeds are not ingested for this stock yet.

Financials

Financial statements and key metrics analysis

Quarter	Revenue (USD)	Operating income	Net income	Diluted EPS (USD)	Filed
Q2 2026	$200.58M	−$514,000	$314,000	$0.01	10-Q · 3 Aug 2026
Q1 2026	$204.58M	−$1.12M	−$11.29M	−$0.39	10-Q · 4 May 2026
Q4 2025	$269.08M	$46.11M	$136.09M	Unavailable	10-K · 13 Feb 2026
Q3 2025	$224.50M	$9.64M	$9.93M	$0.34	10-Q · 3 Nov 2025
Q2 2025	$217.09M	−$3.32M	−$3.59M	−$0.12	10-Q · 4 Aug 2025
Q1 2025	$201.32M	−$1.49M	$2.99M	$0.10	10-Q · 5 May 2025

Source: SEC EDGAR company facts (opens in a new tab)

Analyst Consensus

Neutral

Target: $66.67

-6.8% upside potential

📈

Strong Buy

Unavailable

👍

Buy

4

⏸️

Hold

8

📉

Sell

3

15 analysts covering this stock

Source: Nasdaq analyst research (opens in a new tab) Retrieved 21 Oct 2026, 14:49 UTC Targets range 39.00–97.00 Ratings are third-party opinions, not advice.

💰 Upcoming Dividends

Next dividend payments

Verified Dividend Data Unavailable

Dividend calendar data is not ingested for this stock yet.

Guidance Evolution

Verified Guidance History Unavailable

Verified company guidance history is not ingested for this stock yet.

💼 Director Transactions

Recent insider activity

14

Oct 2026

Ellis Gary Lee

Director

Grant or award

$68.07 per share

431 shares

14

Oct 2026

Melenikiotou Georgia

Director

Grant or award

$68.07 per share

255 shares

14

Oct 2026

CARREL MICHAEL H

Director

Grant or award

$68.07 per share

203 shares

14

Oct 2026

Broader Shelley G

Director

Grant or award

$68.07 per share

284 shares

31

Aug 2026

Kelly Jason P

See Remarks

Grant or award

Unavailable per share

6,350 shares

7

Aug 2026

Kelly Jason P

See Remarks

Open-market sale

$59.55 per share

963 shares

31

Jul 2026

Mann Melissa

Chief People Officer

Tax withholding

$50.21 per share

326 shares

20

Jul 2026

CARREL MICHAEL H

Director

Grant or award

Unavailable per share

5,631 shares

31

Jul 2025

Mann Melissa

Chief People Officer

Tax withholding

$124.54 per share

326 shares

Top Shareholders

Blackrock, Inc.

4,737,519 shares

33.468% change

6/30/2026

Vanguard Group Inc

2,953,170 shares

-1.564% change

12/31/2025

Wellington Management Group Llp

2,382,660 shares

-6.045% change

6/30/2026

Vanguard Portfolio Management Llc

2,088,961 shares

27.596% change

6/30/2026

Soleus Capital Management, L.P.

1,931,436 shares

235.145% change

6/30/2026

Aqr Capital Management Llc

1,856,800 shares

501.564% change

6/30/2026

Ubs Group Ag

1,645,511 shares

157.542% change

6/30/2026

D. E. Shaw & Co., Inc.

1,470,462 shares

23.72% change

6/30/2026

Nomura Holdings Inc

1,369,410 shares

New% change

6/30/2026

Deerfield Management Company, L.P.

1,296,862 shares

-52.026% change

6/30/2026

Source: Nasdaq institutional holdings (opens in a new tab) Observed 21 Oct 2026, 14:49 UTC· 16 hours ago

Research coverage and investment tools

Inspire Medical Systems, Inc. (INSP) is a stock listed on the New York Stock Exchange in the United States, in the Health Care sector (Medical/Dental Instruments). Its last price was US$71.51 on 21 Oct 2026. That is 30% of the way from its 52-week low of US$38.91 to its 52-week high of US$147.03. Its market capitalisation was US$2.07 billion at that price.

Watch Add to portfolio Set an alert Compare Position size

How position sizing works Dividend yield and total return

Quarter	Revenue	Operating income	Net income	Diluted EPS	Gross margin	Operating margin	Free cash flow	Filed
Q2 2026	$200.58M	−$514,000	$314,000	$0.01	85.5%	-0.3%	$14.07M	10-Q · 3 Aug 2026 (opens in a new tab)
Q1 2026	$204.58M	−$1.12M	−$11.29M	−$0.39	86.5%	-0.5%	$3.12M	10-Q · 4 May 2026 (opens in a new tab)
Q4 2025	$269.08M	$46.11M	$136.09M	Unavailable	86.6%	17.1%	$41.81M	10-K · 13 Feb 2026 (opens in a new tab)
Q3 2025	$224.50M	$9.64M	$9.93M	$0.34	85.8%	4.3%	$58.09M	10-Q · 3 Nov 2025 (opens in a new tab)
Q2 2025	$217.09M	−$3.32M	−$3.59M	−$0.12	84.0%	-1.5%	−$6.31M	10-Q · 4 Aug 2025 (opens in a new tab)
Q1 2025	$201.32M	−$1.49M	$2.99M	$0.10	84.7%	-0.7%	−$15.11M	10-Q · 5 May 2025 (opens in a new tab)

Quarter ended	Reported	EPS	Consensus	Surprise
Jun 2026	8/3/2026	$0.14	−$0.22	+163.6%
Mar 2026	5/4/2026	$0.10	−$0.36	+127.8%
Dec 2025	2/11/2026	$1.65	$0.69	+139.1%
Sep 2025	11/3/2025	$0.38	−$0.15	+353.3%

Cash and equivalents: $127.76M
Total assets: $925.99M
Total liabilities: $100.41M
Shareholders' equity: $825.58M
Long-term debt: $21.40M

SCHEDULE 13G/A · 13 Aug 2026

Large-holder ownership filing (opens in a new tab)

A holder reported or amended a beneficial ownership position of more than 5% in Inspire Medical Systems, Inc..
SCHEDULE 13G · 12 Aug 2026

Large-holder ownership filing (opens in a new tab)

A holder reported or amended a beneficial ownership position of more than 5% in Inspire Medical Systems, Inc..
10-Q · 4 Aug 2026

Inspire Medical Systems, Inc. filed Form 10-Q (opens in a new tab)

Inspire Medical Systems, Inc. submitted Form 10-Q to the SEC for the period ending Jun 30, 2026.
8-K · 4 Aug 2026

Inspire Medical Systems, Inc. reported Operating or financial results (opens in a new tab)

Inspire Medical Systems, Inc. filed an 8-K covering operating or financial results, Regulation FD disclosure, supporting financial statements or exhibits.
SCHEDULE 13G/A · 31 Jul 2026

Large-holder ownership filing (opens in a new tab)

A holder reported or amended a beneficial ownership position of more than 5% in Inspire Medical Systems, Inc..

Insider	Date	Transaction	Shares	Average price	Filing
Ellis Gary Lee Director	14 Oct 2026	Grant or award (A)	+431	$68.07	Form 4 (opens in a new tab)
Melenikiotou Georgia Director	14 Oct 2026	Grant or award (A)	+255	$68.07	Form 4 (opens in a new tab)
CARREL MICHAEL H Director	14 Oct 2026	Grant or award (A)	+203	$68.07	Form 4 (opens in a new tab)
Broader Shelley G Director	14 Oct 2026	Grant or award (A)	+284	$68.07	Form 4 (opens in a new tab)
Kelly Jason P See Remarks	31 Aug 2026	Grant or award (A)	+6,350	—	Form 4 (opens in a new tab)
Kelly Jason P See Remarks	7 Aug 2026	Open-market sale (S)	−963	$59.55	Form 4 (opens in a new tab)
Mann Melissa Chief People Officer	31 Jul 2026	Tax withholding (F)	−326	$50.21	Form 4 (opens in a new tab)
CARREL MICHAEL H Director	20 Jul 2026	Grant or award (A)	+5,631	—	Form 4 (opens in a new tab)
Mann Melissa Chief People Officer	31 Jul 2025	Tax withholding (F)	−326	$124.54	Form 4 (opens in a new tab)

Institution	Report date	Shares	Change
Blackrock, Inc.	6/30/2026	4,737,519	33.468%
Vanguard Group Inc	12/31/2025	2,953,170	-1.564%
Wellington Management Group Llp	6/30/2026	2,382,660	-6.045%
Vanguard Portfolio Management Llc	6/30/2026	2,088,961	27.596%
Soleus Capital Management, L.P.	6/30/2026	1,931,436	235.145%
Aqr Capital Management Llc	6/30/2026	1,856,800	501.564%
Ubs Group Ag	6/30/2026	1,645,511	157.542%
D. E. Shaw & Co., Inc.	6/30/2026	1,470,462	23.72%
Nomura Holdings Inc	6/30/2026	1,369,410	New
Deerfield Management Company, L.P.	6/30/2026	1,296,862	-52.026%

Previous close: 71.34 USD
Day range: 70.41 – 72.44 USD
52-week range: 38.91 – 147.03 USD
Volume: 50,858
Market cap: $2.07B
Average volume: 336,702
P/E ratio: 15.3
EPS (FY 2025, diluted): 4.89 USD
Shares outstanding: 28.91M
Beta (5Y monthly): 0.65

Price, ranges and volume: Yahoo Finance (opens in a new tab) Observed 21 Oct 2026, 14:48 UTC· 16 hours ago

Average volume and shares: Nasdaq (opens in a new tab) Observed 22 Oct 2026, 06:33 UTC· 41 minutes ago

P/E is market cap ÷ trailing 12-month net income from SEC filings.

EPS: SEC EDGAR company facts (opens in a new tab)

Beta: 5 years of monthly returns against the S&P 500, calculated from Yahoo Finance prices. Market cap is the price × shares outstanding.

This research is not available for INSP yet

Guidance history

IMPORTANT FINANCIAL DISCLAIMER: The information provided on this platform is for educational and informational purposes only and should not be construed as investment advice. All investments involve risk, including potential loss of principal. Past performance does not guarantee future results. Take Profits is not a registered investment advisor and does not provide personalized investment advice. Users should conduct their own research and consult with qualified financial professionals before making investment decisions. Market data may be delayed and is provided by third-party sources.